跳至主要内容
临床试验/NCT01071525
NCT01071525Unknown3 期

The Effect of Niacin Administration on Oxidative Stress in Patients With Hypercholesterolmia, as Measured by the Use of a Novel Biomarker

Rambam Health Care Campus1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2010年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
入组人数
30
试验地点
1
主要终点
Effect on oxidative stress

研究概览

简要总结

  1. Treatment of Hypercholesterolemic patients with niacin will cause a significant decrease in oxidative stress and a decrease in the atherogenecity in blood samples of the patients.
  2. A possible correlation between oxidative stress in hypercholesterolemic patients taking niacin to clinical hypercholesterolemia parameters is possible.
  3. Using a novel biomarker will enable a precise detection of the change in the oxidative stress in hypercholesterolemic patients.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Hypercholesterolemia,
  • age above eighteen

排除标准

  • Treatment with fibrates,
  • Pregnant/Breast feeding women

研究组 & 干预措施

Niacin

Active Comparator

Hypercholesterolemic patients with high-density lipoprotein (HDL) less than 40 mg% will receive Niacin\Laropiprant.

干预措施: Niacin\Laropiprant (Drug)

Control

No Intervention

Maching subjects will receive no medication, Blood tests will be drawn for laboratory tests.

干预措施: Niacin\Laropiprant (Drug)

结局指标

主要结局

Effect on oxidative stress

时间窗: three months

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验